April 30th 2025
Data showed a disease-free survival rate of 85.3% at 6 months and 81.1% at 9 months.
First patient enrolled in trial of Voro Urologic Scaffold for post-prostatectomy SUI
April 24th 2025"What is truly exciting is the potential for this device to meaningfully improve early and long-term continence rates, which can profoundly impact a patient's recovery and overall quality of life,” says Patrick Daily, MD.